Cyclerion Therapeutics Inc (CYCN): board created 10/30/2019

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Re: None

Wednesday, 10/30/2019 8:08:44 PM

Wednesday, October 30, 2019 8:08:44 PM

board created 10/30/2019

Keep Last Read

Replies (1) Next 10 Prev Next

Form 8-K - Current report • Edgar (US Regulatory) • 06/14/2024 08:05:32 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2024 08:30:34 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 09:05:31 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 12/11/2023 10:09:13 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/04/2023 10:09:55 PM
Cyclerion Appoints Regina Graul, Ph.D., as President • GlobeNewswire Inc. • 12/04/2023 01:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/01/2023 01:01:03 PM
Cyclerion Strengthens Board of Directors with Experienced Company Builder and Cutting-edge Innovator • GlobeNewswire Inc. • 11/30/2023 11:16:56 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/24/2023 06:06:00 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:30:32 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/23/2023 08:58:24 PM
Tisento Launches with $81 Million From Top-Tier Investor Syndicate and Promising Cyclerion Assets • GlobeNewswire Inc. • 07/31/2023 11:00:00 AM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/28/2023 08:48:38 PM

InvestorsHub NewsWire

Only $200 per official company press release!